Corbus Pharmaceuticals Holdings (CRBP) Shares Outstanding (Weighted Average) (2013 - 2025)

Corbus Pharmaceuticals Holdings' Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $17.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 61.35% year-over-year to $17.6 million; the TTM figure through Dec 2025 stood at $17.6 million (up 61.35% YoY), while the FY2025 annual figure was $17.6 million, up 61.35% from the prior year.
• Shares Outstanding (Weighted Average) was $17.6 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $12.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $122.2 million in Q3 2021 to a low of $4.1 million in Q4 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $24.6 million across 5 years, with a median of $9.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) plunged 96.59% in 2022, then jumped 152.23% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.1 million in 2021, then gained by 1.85% to $4.2 million in 2022, then gained by 3.76% to $4.3 million in 2023, then surged by 152.23% to $10.9 million in 2024, then jumped by 61.35% to $17.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $17.6 million (Q4 2025), $12.3 million (Q3 2025), and $12.2 million (Q2 2025), per Business Quant data.